Tokyo, Sept. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063076) titled 'Effects of Heart Rate Variability-Guided and Predetermined Training on Aerobic Performance' on Sept. 28.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Active

Primary Sponsor: Institute - National Institute of Fitness and Sports in Kanoya

Condition: Condition - Healthy adult males Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To determine whether heart rate variability-guided training, in which daily training is prescribed based on heart rate variability, affects aerobic adaptations compared with predetermined training when training monotony is matched between the groups. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - HRV-guided training (HRV-G): During the 4-week training period, daily training is prescribed based on morning heart rate variability (LnRMSSD). Low-intensity continuous cycling is performed for 40 min at the lactate threshold intensity. High-intensity interval cycling consists of 4 sets of 4 min at 90% of heart rate reserve followed by 3 min at 50% of heart rate reserve. High-intensity interval cycling, low-intensity continuous cycling, or rest is prescribed according to morning LnRMSSD. Interventions/Control_2 - Predetermined training (PD): During the 4-week training period, participants perform a predetermined training program. Low-intensity continuous cycling is performed for 40 min at the lactate threshold intensity. High-intensity interval cycling consists of 4 sets of 4 min at 90% of heart rate reserve followed by 3 min at 50% of heart rate reserve. The PD group performs two low-intensity continuous cycling and one High-intensity interval cycling per week.

Eligibility: Age-lower limit - 18 years-old = Gender - Male Key inclusion criteria - Adult males aged 18-25 years. Physically and mentally healthy individuals without known disease. Individuals who exercise regularly. Individuals without physical abnormalities based on their regular health examination and health status at the start of the study. Key exclusion criteria - Individuals with an implanted pacemaker. Individuals taking medication regularly. Individuals with abnormal cardiovascular responses. Individuals with physical abnormalities identified by their regular health examination or health assessment at the start of the study. Target Size - 15

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2024 Year 10 Month 01 Day Date of IRB - 2024 Year 10 Month 18 Day Anticipated trial start date - 2024 Year 10 Month 20 Day Last follow-up date - 2024 Year 12 Month 05 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072207

Disclaimer: Curated by HT Syndication.